Bruker Overview

  • Founded
  • 1960
Founded
  • Status
  • Public
  • Employees
  • 7,400
Employees
  • Stock Symbol
  • BRKR
Stock Symbol
  • Investments
  • 53
  • Share Price
  • $78.75
  • (As of Wednesday Closing)

Bruker General Information

Description

Bruker manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker BioSpin Group, Bruker Calid Group, Bruker Scientific Instruments Nano, and Bruker Energy & Supercon Technologies. The Bruker BioSpin Group and Bruker Calid Group are aggregated into BSI Life Science segment for reporting purposes, and it provides the highest revenue stream to the firm. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. It has its major technical and manufacturing centers in Europe, North America, Southeast Asia, as well as sales offices throughout the world.

Contact Information

Website
www.bruker.com
Formerly Known As
Bruker BioSciences
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 40 Manning Road
  • Billerica, MA 01821
  • United States
+1 (978) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bruker Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$78.75 $77.78 $40.57 - $92.35 $11.7B 151M 632K $1.55

Bruker Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 11,603,974 8,553,242 8,146,454 4,639,826
Revenue 2,264,400 1,987,500 2,072,600 1,895,600
EBITDA 451,700 317,500 370,700 321,000
Net Income 237,500 157,800 197,200 179,700
Total Assets 3,087,000 3,049,000 2,771,500 2,128,600
Total Debt 829,300 912,800 880,900 341,100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bruker Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bruker‘s full profile, request access.

Request a free trial

Bruker Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bruker manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and
Diagnostic Equipment
Billerica, MA
7,400 As of 2020
00000
00000000 00000

000-000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000 000000000
Hercules, CA
0000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bruker Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000-000 0000000000 Corporation Hercules, CA 0000 00000000
You’re viewing 1 of 1 competitors. Get the full list »

Bruker Patents

Bruker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210291163-A1 Operation of a microfluidic device in the analysis of sample substances Pending 19-Mar-2020 0000000000
DE-102020202576-A1 Method for generating a magnetic resonance image Pending 28-Feb-2020 00000000000 0
GB-2592492-A Method for generating a magnetic resonance image Pending 28-Feb-2020 00000000000 0
US-20210270918-A1 Method for generating a magnetic resonance image Pending 28-Feb-2020 00000000000
DE-102020105123-B3 Method for the spectrometric characterization of microorganisms Active 27-Feb-2020 C12Q1/04 0

Bruker Executive Team (24)

Name Title Board Seat Contact Info
Frank Laukien Ph.D Chief Executive Officer & Chairman
Thomas Schuelein President & Managing Director
Mark Munch Ph.D Executive Vice President & President
Falko Busse President
Juergen Srega President
You’re viewing 5 of 24 executive team members. Get the full list »

Bruker Board Members (11)

Name Representing Role Since
Adelene Perkins Self Board Member 000 0000
Bonnie Anderson Self Board Member 000 0000
Cynthia Friend Bruker Board Member 000 0000
Frank Laukien Ph.D Bruker Chief Executive Officer & Chairman 000 0000
Hermann Requardt Ph.D Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Bruker Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bruker Investments & Acquisitions (53)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 10-Mar-2021 0000 00000 000 Diagnostic Equipment 00000 000000
000000 0000000 000 24-Feb-2021 000000000000000000 00.00 Other Healthcare Technology Systems 0000 00000 00.0
00000000 06-Jan-2021 00000 00000 00 00.00 Discovery Tools (Healthcare) 00000 000000
0000000 24-Sep-2020 00000 00000 00 0000 Diagnostic Equipment 00000 000000
PrognomIQ 11-Sep-2020 Early Stage VC 0000 Diagnostic Equipment
You’re viewing 5 of 53 investments and acquisitions. Get the full list »

Bruker Subsidiaries (21)

Company Name Industry Location Founded
Canopy Biosciences Discovery Tools (Healthcare) Saint Louis, MO 2016
0000000 Diagnostic Equipment Heidelberg, Germany 0000
00000 Multimedia and Design Software Bremen, Germany 0000
0000000 Business/Productivity Software Southborough, MA 0000
000000 Monitoring Equipment Salt Lake City, UT 0000
You’re viewing 5 of 21 subsidiaries. Get the full list »

Bruker Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 (000-00 000 19-May-2010 000000000000000000 Completed
  • 000000
00000000 000000000 01-Jun-2007 000000000000000000 Completed
  • 000000
00000000000000 01-Jun-2003 000000000000000000 Completed
  • 000000
GeneFormatics 01-Oct-2001 Early Stage VC 0000 Completed
  • 11 buyers
To view Bruker’s complete exits history, request access »